Want to join the conversation?
$BAX, which develops products that treat hemophilia, kidney disease immune disorders, said it expects 3Q16 adjusted EPS from continuing operations of $0.43-0.45. The company expects sales growth of 2-3% on reported basis and 3-4% on constant currency basis. $BAX anticipates GAAP EPS of $0.25-0.29.
Vine, the unique app from $TWTR is no more! Perfect example for mass products that don't make money!
$CVX posts first profit in a year. Right time to get some shares? My question is, will it sustain this turnaround?
Jeff Bezos, my inspiration next to Steve Jobs is going to review the Everything Store $AMZN's financial results today after hours. As an investor/user, I like Amazon Prime and it's success over several parts of the world. What's your take on Amazon?
Of all the Wall St firms out there, Goldman Sachs $GS is the most revered for the way they're run - hiring the best, highly competitive, a closely-knit peer group and making tons of profits for the shareholders. An interesting interview of its CEO Llyod Blankfein by Carlyle groups chief David Rubenstein